Marc Savas
CIK 1603170 · last filed 2026-10-09
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
WRAP price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
BOX 873
LOS ANGELES, CA 90046
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| WRAP | Director | 339,010 | $1.25 | $423.8K | $0 | 22 | 2026-10-09 |
| SRAX, Inc. (SRAX) Delisted | Director | 11,945 | $0.01 | $133 | $0 | 5 | 2022-01-05 |
Recent Filings · Page 3 of 3
29 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-07-10 | WRAP | Grant (A) | +8,083 | $0 | EDGAR |
| 2023-04-27 | WRAP | Grant (A) | — | $0 | EDGAR |
| 2022-01-05 | SRAX, Inc. (SRAX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-04-20 | SRAX, Inc. (SRAX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-04-17 | SRAX, Inc. (SRAX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-04-17 | SRAX, Inc. (SRAX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-04-19 | SRAX, Inc. (SRAX) Delisted | Grant (A) | +3,774 | $0 | EDGAR |
| 2016-08-18 | — | Grant (A) | +1,923 | $0 | |
| 2016-02-24 | — | Mixed | +38,929 | $30.0K |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.